Cargando…
Severity of COVID-19 and Treatment Strategy for Patient With Diabetes
Coronavirus disease 2019 (COVID-19), which was named by the World Health Organization (WHO) in February 2020, has quickly spread to more than 200 countries around the world and was declared as a global pandemic in March 2020. The severity of the disease makes it more prone to severe symptoms and hig...
Autores principales: | Jin, Shi, Hu, Weina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121170/ https://www.ncbi.nlm.nih.gov/pubmed/33995267 http://dx.doi.org/10.3389/fendo.2021.602735 |
Ejemplares similares
-
COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course
por: Landstra, Cyril P., et al.
Publicado: (2021) -
Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications
por: Xiong, Jiachao, et al.
Publicado: (2021) -
Thyroid Function Abnormalities in COVID-19 Patients
por: Wang, Weibin, et al.
Publicado: (2021) -
Type 2 Diabetes Coagulopathy Proteins May Conflict With Biomarkers Reflective of COVID-19 Severity
por: Moin, Abu Saleh Md, et al.
Publicado: (2021) -
ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study
por: Íñiguez, María, et al.
Publicado: (2021)